{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:44:13Z","timestamp":1782942253223,"version":"3.54.5"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jcf.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:54:29Z","timestamp":1782939269000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8948-4741","authenticated-orcid":false,"given":"Chris","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamarah","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Kalnins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Scheers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Snowball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilschanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0001","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jhn.13298","article-title":"Evolution of nutritional management in children with cystic fibrosis\u2013a narrative review","volume":"37","author":"Smith","year":"2024","journal-title":"Journal of Human Nutrition and Dietetics."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0002","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MCP.0000000000001013","article-title":"Evolving nutritional needs, obesity, and overweight status in cystic fibrosis","volume":"29","author":"Szentpetery","year":"2023","journal-title":"Current Opinion in Pulmonary Medicine."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0003","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/jhn.13214","article-title":"Nutritional management of people living with cystic fibrosis throughout life and disease continuum: Changing times, new challenges","volume":"36","author":"Mailhot","year":"2023","journal-title":"Journal of Human Nutrition and Dietetics."},{"key":"10.1016\/j.jcf.2026.06.010_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(24)00427-2","article-title":"What does the expanding CFTR modulator programme mean for people with cystic fibrosis?","author":"Southern","year":"2025","journal-title":"The Lancet Respiratory Medicine"},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clinical Nutrition"},{"issue":"8","key":"10.1016\/j.jcf.2026.06.010_bib0006","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"Journal of the Academy of Nutrition and Dietetics."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0007","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcf.2019.05.007","article-title":"Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand","volume":"19","author":"van der Haak","year":"2020","journal-title":"Journal of Cystic Fibrosis."},{"key":"10.1016\/j.jcf.2026.06.010_bib0008","article-title":"Brazilian Guidelines for Nutrition in Cystic Fibrosis","volume":"20","author":"Lopes Neri","year":"2022","journal-title":"Einstein (16794508)"},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0009","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","article-title":"Standards for the care of people with cystic fibrosis (CF); Planning for a longer life","volume":"23","author":"Gramegna","year":"2024","journal-title":"Journal of Cystic Fibrosis."},{"key":"10.1016\/j.jcf.2026.06.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.02.004","article-title":"Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR\/TEZACAFTOR\/IVACAFTOR","author":"Katz","year":"2026","journal-title":"J Cyst Fibros."},{"issue":"10431","key":"10.1016\/j.jcf.2026.06.010_bib0011","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"The Lancet."},{"key":"10.1016\/j.jcf.2026.06.010_bib0012","unstructured":"UK CF Trust. UK Cystic Fibrosis Registry, 2023 Annual Data Report. London: 2024. Accessed 23rd June2026 https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2024-11\/CFT_2023_Annual_Data_Report_Oct2024%201.pdf."},{"key":"10.1016\/j.jcf.2026.06.010_bib0013","unstructured":"Department of Health and Social Care. Obesity, physical activity and nutrition profile: May 2026 update. London; 2026."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcf.2021.05.002","article-title":"Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study","volume":"21","author":"Gramegna","year":"2022","journal-title":"J Cyst Fibros."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2019.10.004","article-title":"Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis","volume":"19","author":"Harindhanavudhi","year":"2020","journal-title":"J Cyst Fibros."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0016","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ppul.25811","article-title":"Risk factors for obstructive sleep apnea in cystic fibrosis","volume":"57","author":"Shakkottai","year":"2022","journal-title":"Pediatric pulmonology."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcf.2021.05.002","article-title":"Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study","volume":"21","author":"Gramegna","year":"2022","journal-title":"Journal of Cystic Fibrosis."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0018","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"Journal of Cystic Fibrosis."},{"issue":"9","key":"10.1016\/j.jcf.2026.06.010_bib0019","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.clnu.2019.12.029","article-title":"Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors","volume":"39","author":"Bonhoure","year":"2020","journal-title":"Clin Nutr."},{"key":"10.1016\/j.jcf.2026.06.010_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study","volume":"62","author":"Frost","year":"2023","journal-title":"European Respiratory Journal."},{"key":"10.1016\/j.jcf.2026.06.010_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12992-018-0337-x","article-title":"Obesity stigma as a globalizing health challenge","volume":"14","author":"Brewis","year":"2018","journal-title":"Globalization and health."},{"key":"10.1016\/j.jcf.2026.06.010_bib0022","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1016\/S1569-1993(24)01320-1","article-title":"480 Weight stigma among healthcare professionals treating CF in North America","volume":"23","author":"Dennison","year":"2024","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13008","article-title":"What words should we use to talk about weight? A systematic review of quantitative and qualitative studies examining preferences for weight-related terminology","volume":"21","author":"Puhl","year":"2020","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.jcf.2026.06.010_bib0024","series-title":"Person first language guide: Addressing weight bias","year":"2024"},{"key":"10.1016\/j.jcf.2026.06.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.03.011","article-title":"A paradigm shift in cystic fibrosis nutritional care: Clinicians' views on the management of patients with overweight and obesity","author":"Snowball","year":"2023","journal-title":"J Cyst Fibros."},{"key":"10.1016\/j.jcf.2026.06.010_bib0026","series-title":"Nutritional management of Cystic Fibrosis","year":"2016"},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0027","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc."},{"key":"10.1016\/j.jcf.2026.06.010_bib0028","unstructured":"Cystic Fibrosis Canada. The Canadian Cystic Fibrosis Registry 2023 Annual Data report. Torronto, Canada. 2024. Accessed 23rd June 2026 https:\/\/cystic-fibrosis.cdn.prismic.io\/cystic-fibrosis\/Z9sI9jiBA97GirFZ_2023-Annual-Data-ReportWEB-2-.pd."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0029","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcf.2019.05.007","article-title":"Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand","volume":"19","author":"van der Haak","year":"2020","journal-title":"J Cyst Fibros."},{"key":"10.1016\/j.jcf.2026.06.010_bib0030","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/S1569-1993(24)00627-1","article-title":"P330 Navigating the unknown: an international survey of current dietetic practices for overweight and obesity in people with cystic fibrosis","volume":"23","author":"Snowball","year":"2024","journal-title":"Journal of Cystic Fibrosis."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0031","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ajcnut.2025.09.019","volume":"122","author":"Gonzalez Ramirez","year":"2025","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0032","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1038\/s41598-024-59622-2","article-title":"Elexacaftor\/tezacaftor\/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis","volume":"14","author":"Westh\u00f6lter","year":"2024","journal-title":"Scientific reports."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0033","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"20","key":"10.1016\/j.jcf.2026.06.010_bib0034","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.jcf.2026.06.010_bib0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes care."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0036","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/gerona\/gls092","article-title":"Fat mass loss predicts gain in physical function with intentional weight loss in older adults","volume":"68","author":"Beavers","year":"2013","journal-title":"Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences"},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0037","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"American journal of Diseases of Children."},{"key":"10.1016\/j.jcf.2026.06.010_bib0038","series-title":"ECFSPR annual report 2022","author":"Zolin","year":"2024"},{"issue":"11","key":"10.1016\/j.jcf.2026.06.010_bib0039","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"issue":"18","key":"10.1016\/j.jcf.2026.06.010_bib0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"The New England journal of medicine."},{"issue":"19","key":"10.1016\/j.jcf.2026.06.010_bib0041","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med."},{"issue":"21","key":"10.1016\/j.jcf.2026.06.010_bib0042","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0043","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2023.02.004","article-title":"Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del","volume":"22","author":"Lopez","year":"2023","journal-title":"J Cyst Fibros."},{"key":"10.1016\/j.jcf.2026.06.010_bib0044","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1183\/16000617.0261-2024","article-title":"Managing an ageing cystic fibrosis population: challenges and priorities","volume":"34","author":"Frost","year":"2025","journal-title":"European Respiratory Review."},{"issue":"12","key":"10.1016\/j.jcf.2026.06.010_bib0045","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1017\/S0007114525103760","article-title":"Dietary protein intake and overall diet quality in adults with cystic fibrosis following Elexacaftor\/Tezacaftor\/ivacaftor therapy","volume":"133","author":"Morgan","year":"2025","journal-title":"Br J Nutr."},{"issue":"9","key":"10.1016\/j.jcf.2026.06.010_bib0046","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/jn\/nxaa153","article-title":"A Review of Nutritional Requirements of Adults Aged \u226565 Years in the UK","volume":"150","author":"Dorrington","year":"2020","journal-title":"J Nutr."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0047","first-page":"515","article-title":"Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis","volume":"17","author":"Engelen","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care."},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2026.06.010_bib0048","first-page":"S244","article-title":"Older Adults Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.06.010_bib0049","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1183\/16000617.0071-2024","article-title":"The ageing of people living with cystic fibrosis: what to expect now?","volume":"33","author":"Felipe Montiel","year":"2024","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.jcf.2026.06.010_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601438","article-title":"Cystic Fibrosis Lung Disease in the Aging Population","volume":"12","author":"K\u00fcnzi","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.jcf.2026.06.010_bib0051","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/ncomms5172","article-title":"Chronic inflammation induces telomere dysfunction and accelerates ageing in mice","volume":"2","author":"Jurk","year":"2014","journal-title":"Nat Commun."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0052","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1515\/cclm-2019-0235","article-title":"Telomere length determinants in childhood","volume":"58","author":"Gorenjak","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.jcf.2026.06.010_bib0053","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/jcm10040590","article-title":"Leukocyte Telomere Length Is Not Reduced in Children and Adults with Cystic Fibrosis but Associates with Clinical Characteristics-A Cross-Sectional Study","volume":"10","author":"Glapa-Nowak","year":"2021","journal-title":"J Clin Med."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0054","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies","volume":"50","author":"O'Caoimh","year":"2021","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ageing\/afz032","article-title":"New horizons in frailty: the contingent, the existential and the clinical","volume":"48","author":"Pickard","year":"2019","journal-title":"Age Ageing."},{"issue":"9868","key":"10.1016\/j.jcf.2026.06.010_bib0056","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.06.010_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.HXR.0000511872.94957.5e","article-title":"Cystic Fibrosis: Detecting frailty in an outpatient clinic","volume":"5","author":"Ferguson","year":"2016","journal-title":"Healthy Aging Research."},{"issue":"11","key":"10.1016\/j.jcf.2026.06.010_bib0058","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.healun.2022.07.017","article-title":"Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation","volume":"41","author":"Koutsokera","year":"2022","journal-title":"J Heart Lung Transplant."},{"key":"10.1016\/j.jcf.2026.06.010_bib0059","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/jcm13020585","article-title":"Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study","volume":"13","author":"Iacotucci","year":"2024","journal-title":"J Clin Med."},{"issue":"8","key":"10.1016\/j.jcf.2026.06.010_bib0060","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.clnu.2024.06.020","article-title":"Nutrition for the older adult - Current concepts. Report from an ESPEN symposium","volume":"43","author":"Volkert","year":"2024","journal-title":"Clin Nutr."},{"issue":"7","key":"10.1016\/j.jcf.2026.06.010_bib0061","article-title":"Cardiovascular System Involvement in Cystic Fibrosis","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2026.06.010_bib0062","series-title":"Cystic fibrosis and the cardiovascular system: the unexpected heartache","author":"Hebestreit","year":"2023"},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0063","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/GME.0000000000002155","article-title":"Menopause in people with cystic fibrosis","volume":"30","author":"Prochownik","year":"2023","journal-title":"Menopause."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0064","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ogc.2018.07.012","article-title":"Bone health during the menopause transition and beyond","volume":"45","author":"Karlamangla","year":"2018","journal-title":"Obstetrics and gynecology clinics of North America."},{"issue":"11","key":"10.1016\/j.jcf.2026.06.010_bib0065","article-title":"Prevalence and risk factors for low bone mineral density in adults with cystic fibrosis","volume":"6","author":"Boyle","year":"2022","journal-title":"Journal of Bone and Mineral Research Plus."},{"key":"10.1016\/j.jcf.2026.06.010_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.eprac.2025.04.011","article-title":"Menopause in Cystic Fibrosis: Special Considerations for Bone Health, Menopausal Symptoms, and Treatment","author":"Haroon","year":"2025","journal-title":"Endocrine Practice."},{"key":"10.1016\/j.jcf.2026.06.010_bib0067","series-title":"Annual Data Report 2021","year":"2022"},{"key":"10.1016\/j.jcf.2026.06.010_bib0068","series-title":"German Cystic Fibrosis Registry\u2014Annual report 2023","author":"N\u00e4hrlich","year":"2024"},{"key":"10.1016\/j.jcf.2026.06.010_bib0069","unstructured":"UK CF Trust. UK Cystic Fibrosis Registry, 2023 Annual Data Report. London: 2024. Accessed 26th June2026 https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2024-11\/CFT_2023_Annual_Data_Report_Oct2024%201.pdf."},{"key":"10.1016\/j.jcf.2026.06.010_bib0070","unstructured":"Zolin A, Adamoli A, Bakkeheim E. ECFSPR Annual Report 2023. European Cystic Fibrosis Society Patient Registry: Karup, Denmark, 2025. Accessed 23rd June 2026."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0071","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2022.10.001","article-title":"The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study","volume":"22","author":"Birch","year":"2023","journal-title":"J Cyst Fibros."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0072","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.jcf.2026.06.010_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1043691","article-title":"Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France","volume":"10","author":"Rousset-Jablonski","year":"2022","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0074","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2022","journal-title":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society."},{"key":"10.1016\/j.jcf.2026.06.010_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.03.024","article-title":"Increased gastrointestinal cancer risk in cystic fibrosis: Screening, prevention, and future directions","author":"Cummings","year":"2026","journal-title":"Journal of Cystic Fibrosis."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0076","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2016.07.011","article-title":"Cancer risk among lung transplant recipients with cystic fibrosis","volume":"16","author":"Fink","year":"2017","journal-title":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society."},{"key":"10.1016\/j.jcf.2026.06.010_bib0077","series-title":"Hodson and Geddes' Cystic Fibrosis","article-title":"Cancer and Cystic Fibrosis","author":"Peckham","year":"2023"},{"key":"10.1016\/j.jcf.2026.06.010_bib0078","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-022-07812-1","article-title":"Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review","author":"Caley","year":"2023","journal-title":"Dig Dis Sci."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0079","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","article-title":"Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis","volume":"21","author":"Marsh","year":"2022","journal-title":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jinf.2020.12.027","article-title":"A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and level","volume":"82","author":"Deane","year":"2021","journal-title":"J Infect."},{"issue":"4-5","key":"10.1016\/j.jcf.2026.06.010_bib0081","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/01635581.2025.2466234","article-title":"Impact of Changes in Skeletal Muscle Mass Index on Prognosis During Alternating Chemoradiotherapy in Nasopharyngeal Carcinoma","volume":"77","author":"Ichinose","year":"2025","journal-title":"Nutr Cancer."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0082","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jcsm.12756","article-title":"Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis","volume":"12","author":"Martin","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151799","article-title":"Nutrition Care in Cancer: An Overlooked Part of Patient-Centered Care","volume":"41","author":"Erickson","year":"2025","journal-title":"Semin Oncol Nurs."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0084","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1186\/s12885-025-14558-2","article-title":"Global epidemiological characteristics of malnutrition in cancer patients: a comprehensive meta-analysis and systematic review","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC cancer."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107074","article-title":"Malnutrition in cancer patients: causes, consequences and treatment options","volume":"50","author":"Arends","year":"2024","journal-title":"European Journal of Surgical Oncology."},{"key":"10.1016\/j.jcf.2026.06.010_bib0086","first-page":"24","article-title":"Association of Systemic Inflammation with Dietary Intake, Nutrition Impact Symptoms, and Eating-Related Distress Among Patients with Advanced Cancer","volume":"12","author":"Amano","year":"2024","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0087","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12889-025-21423-1","article-title":"Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005-2018","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Public Health."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0088","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304555","article-title":"Anti-inflammatory effects of elexacaftor\/tezacaftor\/ivacaftor in adults with cystic fibrosis heterozygous for F508del","volume":"19","author":"Jarosz-Griffiths","year":"2024","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0089","article-title":"Heightened mitochondrial respiration in CF cells is normalised by triple CFTR modulator therapy through mechanisms involving calcium","volume":"19","author":"Jarosz-Griffiths","year":"2024","journal-title":"Heliyon"},{"issue":"22","key":"10.1016\/j.jcf.2026.06.010_bib0090","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.3390\/cancers13225735","article-title":"Diabetes and Cancer: Risk, Challenges, Management and Outcomes","volume":"13","author":"Shahid","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.jcf.2026.06.010_bib0091","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0092","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.chest.2021.09.003","article-title":"Cancer in cystic fibrosis: a narrative review of prevalence, risk factors, screening, and treatment challenges: adult cystic fibrosis series","volume":"161","author":"Maisonneuve","year":"2022","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0093","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/01635581.2022.2162090","article-title":"The Impact of Nutritional Support on Survival Outcomes in Patients with Advanced Gastric Adenocarcinoma Treated with Chemotherapy","volume":"75","author":"Sugiyama","year":"2023","journal-title":"Nutr Cancer."},{"key":"10.1016\/j.jcf.2026.06.010_bib0094","first-page":"1","article-title":"Effectiveness of Early Oral Nutritional Supplementation in Preventing Weight Loss in Head and Neck Cancer Patients Undergoing Postoperative Radiotherapy or Chemoradiotherapy: A Prospective Randomized Controlled Trial","author":"Jiang","year":"2025","journal-title":"J Am Nutr Assoc."},{"key":"10.1016\/j.jcf.2026.06.010_bib0095","article-title":"Application of oral nutritional supplements to control body weight loss in postoperative patients suffering from solid tumors: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2025","journal-title":"Front Nutr."},{"issue":"21","key":"10.1016\/j.jcf.2026.06.010_bib0096","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of cancer cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"Journal of Clinical Oncology."},{"key":"10.1016\/j.jcf.2026.06.010_bib0097","doi-asserted-by":"crossref","DOI":"10.1136\/bjsports-2024-108671","article-title":"Association of muscle strength and cardiorespiratory fitness with all-cause and cancer-specific mortality in patients diagnosed with cancer: a systematic review with meta-analysis","author":"Bettariga","year":"2025","journal-title":"Brit J Sport Med."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0098","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13048-025-01607-4","article-title":"The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world study","volume":"18","author":"Liu","year":"2025","journal-title":"J Ovarian Res."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0099","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2018.03.011","article-title":"Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis","volume":"17","author":"Sutherland","year":"2018","journal-title":"J Cyst Fibros."},{"key":"10.1016\/j.jcf.2026.06.010_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.08.004","article-title":"What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes (compared to recommended guidelines) in adults with cystic fibrosis-A systematic review","author":"Greaney","year":"2023","journal-title":"J Cyst Fibros."},{"issue":"8","key":"10.1016\/j.jcf.2026.06.010_bib0101","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jand.2019.01.003","article-title":"The relative contribution of food groups to macronutrient intake in children with cystic fibrosis: A European multicenter assessment","volume":"119","author":"Calvo-Lerma","year":"2019","journal-title":"Journal of the Academy of Nutrition and Dietetics."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0102","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/codi.16472","article-title":"A systematic review of the colorectal microbiome in adult cystic fibrosis patients","volume":"25","author":"Gilbert","year":"2023","journal-title":"Colorectal Disease."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0103","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Scientific Reports."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0104","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2156254","article-title":"Diet and the gut-lung axis in cystic fibrosis - direct & indirect links","volume":"15","author":"McKay","year":"2023","journal-title":"Gut Microbes."},{"issue":"12","key":"10.1016\/j.jcf.2026.06.010_bib0105","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.3390\/nu15122749","article-title":"Global impacts of western diet and its effects on metabolism and health: a narrative review","volume":"15","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0106","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/aje\/148.1.4-a","article-title":"Eating patterns and risk of colon cancer","volume":"148","author":"Slattery","year":"1998","journal-title":"American journal of epidemiology"},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0107","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: a comprehensive dose\u2013response meta-analysis","volume":"112","author":"Bagnardi","year":"2015","journal-title":"British journal of cancer."},{"key":"10.1016\/j.jcf.2026.06.010_bib0108","first-page":"1","article-title":"Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies","author":"Ungvari","year":"2025","journal-title":"GeroScience."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0109","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12885-023-11218-1","article-title":"Association of meat consumption with the risk of gastrointestinal cancers: a systematic review and meta-analysis","volume":"23","author":"Di","year":"2023","journal-title":"BMC cancer."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcf.2019.06.004","article-title":"Self-reported alcohol use in the cystic fibrosis community","volume":"19","author":"Lowery","year":"2020","journal-title":"Journal of Cystic Fibrosis."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0111","first-page":"245","article-title":"American Cancer Society guideline for diet and physical activity for cancer prevention","volume":"70","author":"Rock","year":"2020","journal-title":"CA: a cancer journal for clinicians."},{"key":"10.1016\/j.jcf.2026.06.010_bib0112","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202502-170OC","article-title":"Elevated Rates and Earlier Onset of Non-Pulmonary Comorbidities in Adults with Cystic Fibrosis: A Population-Based Study","author":"Arya","year":"2025","journal-title":"Annals of the American Thoracic Society"},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1741-7015-12-112","article-title":"Definitions and potential health benefits of the Mediterranean diet: views from experts around the world","volume":"12","author":"Trichopoulou","year":"2014","journal-title":"BMC medicine."},{"issue":"16","key":"10.1016\/j.jcf.2026.06.010_bib0114","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure","volume":"336","author":"Appel","year":"1997","journal-title":"New England journal of medicine."},{"key":"10.1016\/j.jcf.2026.06.010_bib0115","series-title":"Dietary fats and cardiovascular disease: an Evidence Check rapid review brokered by the Sax Institute for the National Heart Foundation of Australia","author":"Clifton","year":"2017"},{"issue":"S1","key":"10.1016\/j.jcf.2026.06.010_bib0116","doi-asserted-by":"crossref","first-page":"s6","DOI":"10.1017\/S136898002200218X","article-title":"Population-level salt intake in the WHO European Region in 2022: a systematic review","volume":"26","author":"Kwong","year":"2023","journal-title":"Public Health Nutrition."},{"issue":"24","key":"10.1016\/j.jcf.2026.06.010_bib0117","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.3390\/nu15245013","article-title":"Association between dietary intake and faecal microbiota in children with cystic fibrosis","volume":"15","author":"Viteri-Echeverr\u00eda","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0118","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnu.2023.11.005","article-title":"Dietary fiber intake and all-cause and cause-specific mortality: An updated systematic review and meta-analysis of prospective cohort studies","volume":"43","author":"Ramezani","year":"2024","journal-title":"Clinical Nutrition."},{"issue":"27","key":"10.1016\/j.jcf.2026.06.010_bib0119","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1080\/10408398.2022.2061909","article-title":"Dietary fiber in the prevention of obesity and obesity-related chronic diseases: From epidemiological evidence to potential molecular mechanisms","volume":"63","author":"Waddell","year":"2023","journal-title":"Critical reviews in food science and nutrition."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ajcn\/nqaa063","article-title":"Associations between consumption of dietary fibers and the risk of cardiovascular diseases, cancers, type 2 diabetes, and mortality in the prospective NutriNet-Sant\u00e9 cohort","volume":"112","author":"Partula","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.jcf.2026.06.010_bib0121","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clnu.2024.09.036","article-title":"The impact of a whole foods dietary intervention on gastrointestinal symptoms, inflammation, and fecal microbiota in pediatric patients with cystic fibrosis: A pilot study","volume":"43","author":"Green","year":"2024","journal-title":"Clinical Nutrition."},{"key":"10.1016\/j.jcf.2026.06.010_bib0122","article-title":"Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses","volume":"384","author":"Lane","year":"2024","journal-title":"BMJ."},{"issue":"11","key":"10.1016\/j.jcf.2026.06.010_bib0123","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1080\/10408398.2024.2317877","article-title":"Ultra-processed food consumption and human health: an umbrella review of systematic reviews with meta-analyses","volume":"65","author":"Barbaresko","year":"2025","journal-title":"Critical reviews in food science and nutrition."},{"key":"10.1016\/j.jcf.2026.06.010_bib0124","article-title":"Impact of the consumption of ultra-processed foods on children, adolescents and adults\u2019 health: Scope review","volume":"37","author":"Louzada","year":"2022","journal-title":"Cadernos de Sa\u00fade P\u00fablica."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0125","first-page":"149","article-title":"Cystic fibrosis of the pancreas. Morphologic findings in infants with and without diagnostic pancreatic lesions","volume":"96","author":"Oppenheimer","year":"1973","journal-title":"Archives of pathology."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<172::AID-PPUL3>3.0.CO;2-1","article-title":"Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis","volume":"29","author":"Cade","year":"2000","journal-title":"Pediatric pulmonology."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0127","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3476(82)80501-5","article-title":"Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption","volume":"100","author":"Gaskin","year":"1982","journal-title":"The Journal of pediatrics."},{"issue":"10408","key":"10.1016\/j.jcf.2026.06.010_bib0128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"The Lancet."},{"issue":"7","key":"10.1016\/j.jcf.2026.06.010_bib0129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","article-title":"Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study","volume":"6","author":"Rosenfeld","year":"2018","journal-title":"Lancet Respir Med."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2\u20135 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study","volume":"4","author":"Davies","year":"2016","journal-title":"The Lancet Respiratory Medicine."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0131","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcf.2019.03.009","article-title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2\u20135 years (KLIMB)","volume":"18","author":"Rosenfeld","year":"2019","journal-title":"Journal of cystic fibrosis."},{"key":"10.1016\/j.jcf.2026.06.010_bib0132","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J Pediatr."},{"key":"10.1016\/j.jcf.2026.06.010_bib0133","first-page":"99","article-title":"Restoration of exocrine pancreatic function in older children with cystic fibrosis on ivacaftor","volume":"35","author":"Nichols","year":"2020","journal-title":"Paediatr Respir Rev."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0134","first-page":"6","article-title":"Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor","volume":"7","author":"Petrocheilou","year":"2020","journal-title":"Children (Basel)"},{"issue":"10","key":"10.1016\/j.jcf.2026.06.010_bib0135","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/ppul.24952","article-title":"Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor","volume":"55","author":"Smith","year":"2020","journal-title":"Pediatr Pulmonol."},{"issue":"11","key":"10.1016\/j.jcf.2026.06.010_bib0136","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ppul.24454","article-title":"Pancreatic insufficiency converted to pancreatic sufficiency with ivacaftor","volume":"54","author":"Hamilton","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2026.06.010_bib0137","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1002\/ppul.24353","article-title":"Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use","volume":"54","author":"Megalaa","year":"2019","journal-title":"Pediatr Pulmonol."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0138","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcf.2021.09.010","article-title":"CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis","volume":"21","author":"Gould","year":"2022","journal-title":"Journal of Cystic Fibrosis."},{"issue":"12","key":"10.1016\/j.jcf.2026.06.010_bib0139","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/ppul.25065","article-title":"Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor","volume":"55","author":"Munce","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.jcf.2026.06.010_bib0140","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41395-018-0123-7","article-title":"Ivacaftor CFTR Potentiator Therapy is Efficient for Pancreatic Manifestations in Cystic Fibrosis","volume":"113","author":"Kounis","year":"2018","journal-title":"The American journal of gastroenterology."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0141","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(16)30032-7","article-title":"Partial restoration of pancreatic function in a child with cystic fibrosis","volume":"4","author":"Howlett","year":"2016","journal-title":"Lancet Respir Med."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0142","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1513\/AnnalsATS.202006-614RL","article-title":"Appearance of pancreatic sufficiency and discontinuation of pancreatic enzyme replacement therapy in children with cystic fibrosis on ivacaftor","volume":"18","author":"Hutchinson","year":"2021","journal-title":"Annals of the American Thoracic Society."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0143","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-2600(18)30460-0","article-title":"Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2\u20135 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study","volume":"7","author":"McNamara","year":"2019","journal-title":"The Lancet Respiratory Medicine."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0144","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ppul.25781","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on vitamin D absorption in cystic fibrosis patients","volume":"57","author":"Wright","year":"2022","journal-title":"Pediatric Pulmonology."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1656","article-title":"Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype","volume":"9","author":"Terlizzi","year":"2021","journal-title":"Molecular genetics & genomic medicine."},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0146","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2020.07.023","volume":"20","author":"Davies","year":"2021","journal-title":"Journal of Cystic Fibrosis."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0147","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI","volume":"22","author":"Schwarzenberg","year":"2023","journal-title":"Journal of cystic fibrosis."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0148","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcf.2023.10.001","article-title":"Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged\u2265 12 years\u2013The RECOVER study","volume":"23","author":"Mainz","year":"2024","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0149","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jcf.2023.09.005","article-title":"Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis","volume":"22","author":"Stephenson","year":"2023","journal-title":"Journal of Cystic Fibrosis."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000538606","article-title":"Improved nutritional outcomes and gastrointestinal symptoms in adult cystic fibrosis patients treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"42","author":"Stastna","year":"2024","journal-title":"Digestive Diseases."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0151","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcf.2022.04.005","article-title":"A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus","volume":"21","author":"Szentpetery","year":"2022","journal-title":"Journal of Cystic Fibrosis."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0152","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000530261","article-title":"Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis","volume":"50","author":"Gomez-Montes","year":"2023","journal-title":"Fetal diagnosis and therapy."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0153","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcf.2021.03.018","article-title":"Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy","volume":"20","author":"Fortner","year":"2021","journal-title":"Journal of Cystic Fibrosis."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0154","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcf.2022.08.008","article-title":"Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review","volume":"22","author":"Ramsey","year":"2023","journal-title":"Journal of Cystic Fibrosis."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71156","article-title":"Impact of Elexacaftor\/Tezacaftor\/Ivacaftor on Fecal Elastase-1 in Children With Cystic Fibrosis","volume":"60","author":"Sankararaman","year":"2025","journal-title":"Pediatric Pulmonology"},{"key":"10.1016\/j.jcf.2026.06.010_bib0156","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.70061","article-title":"Diagnostic Accuracy of Fecal Elastase-1 Test for Pancreatic Exocrine Insufficiency: A Systematic Review and Meta-Analysis","author":"de la Iglesia","year":"2025","journal-title":"United European Gastroenterology Journal"},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0157","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MOP.0000000000000934","article-title":"Pancreatic complications in children with cystic fibrosis","volume":"32","author":"Sellers","year":"2020","journal-title":"Current opinion in pediatrics."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0158","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jcf.2024.01.011","article-title":"Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries","volume":"23","author":"Calthorpe","year":"2024","journal-title":"Journal of Cystic Fibrosis."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0159","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","article-title":"Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy","volume":"127","author":"Borowitz","year":"1995","journal-title":"The Journal of pediatrics."},{"key":"10.1016\/j.jcf.2026.06.010_bib0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/nu14071341","article-title":"Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis","volume":"14","author":"Freswick","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0161","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPG.0000000000000784","article-title":"Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis","volume":"61","author":"Woestenenk","year":"2015","journal-title":"Journal of pediatric gastroenterology and nutrition"},{"issue":"1","key":"10.1016\/j.jcf.2026.06.010_bib0162","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/ajcn\/69.1.127","article-title":"Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids","volume":"69","author":"Kalivianakis","year":"1999","journal-title":"The American journal of clinical nutrition."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0163","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr."},{"issue":"6","key":"10.1016\/j.jcf.2026.06.010_bib0164","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcf.2016.08.004","article-title":"Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines","volume":"15","author":"Schwarzenberg","year":"2016","journal-title":"Journal of cystic fibrosis."},{"issue":"4","key":"10.1016\/j.jcf.2026.06.010_bib0165","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41430-020-00782-5","article-title":"Long-term use of tube feeding in children with cystic fibrosis: results from two Belgian CF centers","volume":"75","author":"Declercq","year":"2021","journal-title":"European journal of clinical nutrition."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0166","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jcf.2018.01.004","article-title":"The effect of enteral tube feeding in cystic fibrosis: a registry based study","volume":"17","author":"Libeert","year":"2018","journal-title":"Journal of Cystic Fibrosis."},{"key":"10.1016\/j.jcf.2026.06.010_bib0167","unstructured":"Cystic Fibrosis Foundation. Annual Data Report 2024. Bethesda, Maryland: 2025."},{"issue":"5","key":"10.1016\/j.jcf.2026.06.010_bib0168","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jcf.2024.01.007","article-title":"An emotional journey: caregiver experiences with gastrostomy tube decision-making for children with cystic fibrosis","volume":"23","author":"Dickinson","year":"2024","journal-title":"Journal of Cystic Fibrosis."},{"issue":"3","key":"10.1016\/j.jcf.2026.06.010_bib0169","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MPG.0000000000003207","article-title":"Percutaneous endoscopic gastrostomy in children: an update to the ESPGHAN position paper","volume":"73","author":"Homan","year":"2021","journal-title":"Journal of pediatric gastroenterology and nutrition."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ncp.10263","article-title":"Clinical biopsychosocial reflection on coping with chronic illness and reliance upon nutrition support: an integrated healthcare approach","volume":"34","author":"Price","year":"2019","journal-title":"Nutrition in Clinical Practice."},{"key":"10.1016\/j.jcf.2026.06.010_bib0171","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1163391","article-title":"Real-world disparities and ethical considerations with access to CFTR modulator drugs: mind the gap!","volume":"14","author":"Zampoli","year":"2023","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.jcf.2026.06.010_bib0172","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/13993003.01241-2023","article-title":"Cystic fibrosis in Europe: improved lung function and longevity\u2013reasons for cautious optimism, but challenges remain","volume":"63","author":"Kerem","year":"2024","journal-title":"European Respiratory Journal."},{"issue":"2","key":"10.1016\/j.jcf.2026.06.010_bib0173","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1513\/AnnalsATS.202501-052OC","article-title":"Health inequity in people with cystic fibrosis: can we close the gap?","volume":"23","author":"Sermet-Gaudelus","year":"2026","journal-title":"Ann Am Thorac Soc."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326016504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326016504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:54:59Z","timestamp":1782939299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326016504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":173,"alternative-id":["S1569199326016504"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.06.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}